CMA

Cedar Mountain Advisors Portfolio holdings

AUM $481M
This Quarter Return
-0.51%
1 Year Return
+12.72%
3 Year Return
+47.96%
5 Year Return
+81.01%
10 Year Return
AUM
$301M
AUM Growth
+$301M
Cap. Flow
-$540K
Cap. Flow %
-0.18%
Top 10 Hldgs %
89.8%
Holding
331
New
32
Increased
60
Reduced
37
Closed
5

Sector Composition

1 Technology 2.19%
2 Industrials 0.98%
3 Consumer Discretionary 0.87%
4 Consumer Staples 0.7%
5 Financials 0.39%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ONCY
151
Oncolytics Biotech
ONCY
$117M
$12K ﹤0.01%
5,651
SWK icon
152
Stanley Black & Decker
SWK
$11.3B
$12K ﹤0.01%
70
ETY icon
153
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.49B
$11K ﹤0.01%
768
EXC icon
154
Exelon
EXC
$43.8B
$11K ﹤0.01%
225
FDX icon
155
FedEx
FDX
$53.2B
$11K ﹤0.01%
49
GILD icon
156
Gilead Sciences
GILD
$140B
$11K ﹤0.01%
+151
New +$11K
GOOD
157
Gladstone Commercial Corp
GOOD
$609M
$11K ﹤0.01%
527
IMCG icon
158
iShares Morningstar Mid-Cap Growth ETF
IMCG
$2.87B
$11K ﹤0.01%
156
JD icon
159
JD.com
JD
$44.2B
$11K ﹤0.01%
+159
New +$11K
NWL icon
160
Newell Brands
NWL
$2.64B
$11K ﹤0.01%
475
UMC icon
161
United Microelectronic
UMC
$16.7B
$11K ﹤0.01%
1,000
VTRS icon
162
Viatris
VTRS
$12.3B
$11K ﹤0.01%
830
-8
-1% -$106
COUP
163
DELISTED
Coupa Software Incorporated
COUP
$11K ﹤0.01%
50
EYPT icon
164
EyePoint Pharmaceuticals
EYPT
$827M
$10K ﹤0.01%
1,000
FVRR icon
165
Fiverr
FVRR
$864M
$10K ﹤0.01%
55
MET icon
166
MetLife
MET
$53.6B
$10K ﹤0.01%
+169
New +$10K
MRK icon
167
Merck
MRK
$210B
$10K ﹤0.01%
132
+1
+0.8% +$76
SCHA icon
168
Schwab U.S Small- Cap ETF
SCHA
$18.4B
$10K ﹤0.01%
98
-42
-30% -$4.29K
TFC icon
169
Truist Financial
TFC
$59.8B
$10K ﹤0.01%
+163
New +$10K
TREX icon
170
Trex
TREX
$6.41B
$10K ﹤0.01%
96
VEA icon
171
Vanguard FTSE Developed Markets ETF
VEA
$169B
$10K ﹤0.01%
+200
New +$10K
FPL
172
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
$10K ﹤0.01%
1,689
NSTG
173
DELISTED
NanoString Technologies, Inc.
NSTG
$10K ﹤0.01%
206
ATI icon
174
ATI
ATI
$10.5B
$9K ﹤0.01%
535
BMY icon
175
Bristol-Myers Squibb
BMY
$96.7B
$9K ﹤0.01%
158